PALB2 and ovarian carcinoma: Biallelic mutations in PALB2 cause Fanconi anemia, while monoallelic PALB2 mutations are associated with breast and ovarian cancer, carrying an estimated absolute lifetime risk of 41 – 60% and 35%, respectively.